Stay updated on Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Gastric Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications section wording updated to clarify that publications are provided voluntarily by submitters and that PubMed items are auto-filled; Revision: v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the notice about a lapse in government funding and NIH operating status; the page no longer informs users about potential delays and updates to operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedNo additions or deletions were detected; the page content remains focused on study details and eligibility criteria.SummaryDifference0.4%

- Check71 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference2%

- Check78 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.1%

- Check93 days agoChange DetectedUpdated to Revision: v3.0.2 from v3.0.1; the 'Back to Top' link/button was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.